Development and validation of a stability-indicating LC method to quantify hydrochlorothiazide in oral suspension for pediatric use

Chromatographia

Volumn 67, Issue 7-8, 2008, Pages 647-652

  Tagliari, Monika Piazzon ^a   Stulzer, Hellen Karine ^a   Murakami, Fabio Seigi ^a   Kuminek, Gislaine ^a   Valente, Bruno ^a   Oliveira, Paulo Renato ^a   Segatto Silva, Marcos Antonio ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Column liquid chromatography; Hydrochlorothiazide; Pediatric oral suspension; Stability indicating; Validation

Indexed keywords

HYDROCHLOROTHIAZIDE;

ARTICLE; COLUMN CHROMATOGRAPHY; DRUG ANALYSIS; DRUG FORMULATION; DRUG STABILITY; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 41849115226     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-008-0546-1     Document Type: Article

References (22)

1. Michele TM, Knorr B, Vadas EB, Reiss TF (2002) J Asthma 39:391-403
2. Nahata MC Pediatric (1999) Ann Pharmacother 33:247-249
3. Kayumba PC, Huyghebaert N, Cordella C, Ntawukuliryayo JD, Vervaet C (2007) Eur J Pharmaceut Biopharmaceut 66:460-465
4. Freed AL, Silbering SB, Kolodsick KJ, Rossi DT, Mahjour M, Kingsmill CA (2005) Int J Pharm 304:135-144
5. Litwin M, Sladowska J, Antoniewicz J, Niemirska A, Wierzbicka A, Daszkowska J, Wawer ZT, Janas R, Grenda R (2007) Am J Hypertens 20:875-882
6. Moffat A, Osselton M, Widdop B (2004) In: Clarke's Analysis of Drugs and Poisons, Pharmaceutical Press, London
7. Carter BL, Ernst ME, Cohen JD (2004) Hypertension 43:4-9
8. European Pharmacopoeia (2001) 3rd edn, p 2966
9. The United States Pharmacopoeia (2007) 30 Revision. United States Pharmacopeial Convention, Rockeville, p 2288
10. Carlucci G, Palumbo G, Mazzeo P, Quaglia MG (2000) J Pharm Biomed Anal 23:185-189
11. Erk N (1999) J Pharm Biomed Anal 20:155-167
12. Dinç E, Özdemir A (2005) Il Farmaco 60:591-597
13. El-Gindy A, Ashour A, Abdel-Fattah L, Shabana MM (2001) J Pharm Biomed Anal 25:923-931
14. Quaglia MG, Donati E, Carlucci G, Mazzeo, Fanali S (2002) J Pharm Biomed Anal 29:981-987
15. Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL (2003) Am J Health Syst Pharm 60:69-74
16. Flynn JT, Daniels SR (2006) J Pediatr 149:746-54
17. Trissel L (2005) In: Trissel's stability of compounded formulations. American Pharmaceutical Association, Washington
18. Shabir GA, Lough WJ, Arain SA, Bradshaw TK (2007) J Liq Chromatogr Related Technol 30:311-333
19. ICH (2005) Harmonised tripartite guideline: validation of analytical procedures: text and methodology Q2 (R1)
20. Vadera N, Subramanian G, Musmade P (2007) J Pharm Biomed Anal 43:722-726
21. Lusina M, Cindric T, Tomaic J, Peko M, Pozaic L, Musulin N (2005) Int J Pharm 291:127-137
22. Hertzog DL, McCafferty JF, Fang X, Tyrrell RJ, Reed RA (2002) J Pharm Biomed Anal 30:747-760